The Atlas pH Monitoring and Control Systems are for chemists who perform pH sensitive reactions. They allow the pH value to be monitored and logged throughout a reaction and the pH value to be controlled using the Atlas Syringe Pump by addition of an acid and/or base.
Atlas from Syrris is a family of high performance, low cost synthesis systems that are flexible and truly easy to use. The Atlas pH Monitoring System is based on the Atlas Potassium System for jacketed reactors and the temperature node is replaced by the pH and temperature Node and pH probe.
The pH control system also includes an Atlas Syringe Pump and can therefore be configured to control the pH of a reaction by adding either acid and/or base as necessary to maintain a set pH value. The Syringe Pump will automatically refill with both materials as they become exhausted.
Features & Benefits
• Easy to use: All parts click together without the need for tools - the pH and temperature node clips onto the support rods and is automatically detected by the Atlas Base.
• Intelligent: pH can be maintained by the addition of an acid and/or base without PC control.
• Automatic data logging: All data including pH is shown on the base in real time and automatically logged to a .csv file.
• Powerful: Parameters including temperature, stirrer speed and quantity of acid/base added can be controlled from the Atlas Base.
• Wide temperature and pH range: pH measurement up to 100°C and pH values 0-14 (note that the rest of the system is suitable for use from -80°C to +200°C).
• Temperature compensation: When the pH and temperature are monitored together, the pH is automatically temperature compensated.
• Quick: With an easy to use vessel clamping system and integral oil drain unit, Atlas jacketed vessels can be changed in under a minute.
Compact size: Fits conveniently in a regular fume cupboard. Robust: Specifically designed for use in chemical laboratories
Keeping Tumor Growth at Bay Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.Future of Medicine Could be Found in a Tiny Crystal Ball A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.Improving Delivery of Poorly Soluble Drugs Using Nanoparticles A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.Faster Drug Discovery? Startup develops more cost-effective test for assessing how cells respond to chemicals.New Mechanism of Antitumor Action Identified A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.Nanoparticles Deliver Tumor Suppressors to Damaged Livers UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.Experimental Combination Surprises with Anti-HIV Effectiveness A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.A New Type of Anticancer Agent Success in the development of a ?-tubulin specific inhibitor.Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs” In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.Versatile New Molecule-Building Technique Chemists at The Scripps Research Institute (TSRI) have devised a new and widely applicable technique for building potential drug molecules and other organic compounds.